ArticleThe Journal of endocrinology2023

Apoptosis-modulatory miR-361-3p as a novel treatment target in endocrine-responsive and endocrine-resistant breast cancer.

J N Zamarbide Losada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.